1. Home
  2. Unknown
  3. Washington, DC
  4. Melanoma Research Foundation

Melanoma Research Foundation

Melanoma Research Foundation is ranked #13 of 18 unknown organizations in Washington, DC, with an America's Best Score of 67 out of 100, based on its 2025 Form 990.

  • Washington, DC
  • Tax-exempt since 1996
  • EIN: 76-0514428
melanoma.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
67OF 100 #13 of 18 in Washington ranked unknown organizations How this score is calculated

Organization summary

Melanoma Research Foundation is a 501(c)(3) organization, classified under Unknown (NTEE Z99). Contributions are tax-deductible.

1420 K St Nw Ste 700, Washington, DC 20005-2516

Among the 32 scored unknown organizations in Washington, Melanoma Research Foundation holds 8.6 months of operating reserves (peer median 8.2 months), runs a typical yearly surplus of 7.4% (peers: deficit of 1.6%), and has grown spending 3.2% a year (peers: grown spending 7.1% a year).

In fiscal year 2025 it reported $7,413,825 in revenue and $6,905,774 in expenses, with contributions making up 109.1% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

The mrf is the largest independent organization devoted to melanoma. Its mission is to eradicate melanoma by accelerating medical research while educating to and advocating for the melanoma community.

Largest programs · fiscal year 2024

  • The mrf is committed to advancing a broad scientific agenda across the disciplines of prevention, diagnosis, and treatment. Although the mrf has achieved a number of important scientific milestones, much more work remains to be done. To this end, the mrf funds a spectrum of research grants, scientific initiatives, and programs for cutaneous melanoma and rarer melanoma subtypes (e.g. Ocular, pediat… Read more

    The mrf is committed to advancing a broad scientific agenda across the disciplines of prevention, diagnosis, and treatment. Although the mrf has achieved a number of important scientific milestones, much more work remains to be done. To this end, the mrf funds a spectrum of research grants, scientific initiatives, and programs for cutaneous melanoma and rarer melanoma subtypes (e.g. Ocular, pediatric, acral and mucosal melanoma). Its research grant program is a competitive, peer-reviewed research grant program for investigator-initiated research has been in existence since 1998. Mrf-supported research is open to medical students through senior investigative teams and encompass.

    $3,553,571 spent · 65.1% of program spending
  • The mrf's advocacy program is a platform for those affected by melanoma to share their voice and transform melanoma care. Patients, caregivers, survivors, healthcare professionals and partners all play a critical role in the advancement of better outcomes for the over one million Americans living with melanoma and their loved ones. $1,130,850 spent · 20.7% of program spending
  • The mrf has a robust education program aimed at educating patients and physicians about the prevention, diagnosis, and treatment of melanoma, as well as increasing overall awareness of the disease. In addition, the mrf maintains a large portfolio of free educational materials that can be used at fundraisers, doctors' offices, schools, and health fairs.part of the mrf's educational offerings also i… Read more

    The mrf has a robust education program aimed at educating patients and physicians about the prevention, diagnosis, and treatment of melanoma, as well as increasing overall awareness of the disease. In addition, the mrf maintains a large portfolio of free educational materials that can be used at fundraisers, doctors' offices, schools, and health fairs.part of the mrf's educational offerings also include patient-focused educational symposia throughout the U.S., impacting nearly 1,500 people touched by melanoma. These symposia provide melanoma patients and the people who support them the opportunity to learn from leading melanoma experts on the most current prevention, diagnosis, treatment, and research information.

    $776,432 spent · 14.2% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 82¢ went to programs, 11¢ to management and 7¢ to fundraising.

  • Programs $5,460,853
  • Management $773,502
  • Fundraising $462,864

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score67 / 100
Rank in Washington#13 of 18
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves8.6 mo; 1.5 mo in cash6 / 25
Financial balance (median margin)+7.4%18.5 / 20
Transparency3 full 990s, latest TY202520 / 20
Program growth+3.2% / yr9.1 / 15
Track record30 years10 / 10
Debt load40.4% of assets3.9 / 10
Total67.5 → 67
Spending on programs
Not scored; America's Best needs 65%+
82%Meets

Compared with Washington peers

MeasureThis organizationPeer median
Operating reserves8.6 mo8.2 mo
Typical margin+7.4%−1.6%
Spending growth+3.2% / yr+7.1% / yr
Debt load40.4%23.6%

Peers: the 32 Washington unknown organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$7,413,825Fiscal year 20252023: $6,578,22320232024: $7,774,56220242025: $7,413,8252025
Expenses$6,905,774Fiscal year 20252023: $6,478,76020232024: $6,697,21920242025: $6,905,7742025
Total assets$8,283,039Fiscal year 20252023: $6,173,37420232024: $7,270,87220242025: $8,283,0392025
Total liabilities$3,344,115Fiscal year 20252023: $2,965,71720232024: $2,821,97120242025: $3,344,1152025
Fiscal year ending March 2025
Revenue$7,413,825
Expenses$6,905,774
Net income$508,051
Net assets$4,938,924

Notable sources of revenue

Percent of total revenue
Contributions$8,089,338
Program services$0
Investment income$118,973
Other (net)−$794,486

Assets / debt

Total assets$8,283,039
Total liabilities$3,344,115
Net assets$4,938,924

Compensation

Not in our extract for this year.

Fiscal year ending March 2024
Revenue$7,774,562
Expenses$6,697,219
Net income$1,077,343
Net assets$4,448,901

Notable sources of revenue

Percent of total revenue
Contributions$8,303,636
Program services$0
Investment income$242,977
Other (net)−$772,051

Assets / debt

Total assets$7,270,872
Total liabilities$2,821,971
Net assets$4,448,901

Compensation

Not in our extract for this year.

Fiscal year ending March 2023
Revenue$6,578,223
Expenses$6,478,760
Net income$99,463
Net assets$3,207,657

Notable sources of revenue

Percent of total revenue
Contributions$7,217,360
Program services$0
Investment income$26,440
Other (net)−$665,577

Assets / debt

Total assets$6,173,374
Total liabilities$2,965,717
Net assets$3,207,657

Compensation

Officers and key employees$334,735
Share of expenses5.2%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?